JANX logo

Janux Therapeutics, Inc. (JANX)

Profile

Full Name

Janux Therapeutics, Inc.

Ticker

NASDAQ: JANX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 11, 2021

Indexes

Not included

Website

https://www.januxrx.com

Employees

91

Key Details

Price

$23.56(-1.89%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$10.59M(+30.99% YoY)

Annual EPS

-$1.28(+3.03% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $23.56
    JANX price is $23.56

    30-Day Relative Volume

    0.72
    JANX 30-day relative volume is 0.72

    Price Performance

    Price Most recent change

    -1.89%
    JANX price was down -1.89% on Aug 1, 2025

    Price YTD change

    -56%
    JANX price is down -56% since January 1st

    Price 1-year change

    -43.17%
    JANX price is down -43.17% year-on-year

    Price 3-year change

    +103.98%
    JANX price is up +103.98% over the past 3 years

    Price Range

    Price All-time high

    $71.71
    JANX price is currently -67.15% below its historical high of $71.71

    Price 3-year low

    $5.65
    JANX price is currently +316.99% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.39B
    JANX market capitalization is $1.39 billion

    Market cap 3-year change

    +190.85%
    JANX market capitalization is up +190.85% over the past 3 years

    Market cap All-time high

    $3.79B
    JANX market capitalization is currently -63.25% below its historical high of $3.79 billion

    Market cap sector rank

    78.2%
    JANX market capitalization is higher than 78.2% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +13.44%
    JANX shares outstanding is up +13.44% year-on-year

    Shares Outstanding 3-Year Change

    +42.59%
    JANX shares outstanding is up +42.59% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.24
    JANX beta is 1.24

    200-day SMA

    $37.27
    JANX price is currently -36.78% below its 200-day simple moving average

    50-day SMA

    $24.79
    JANX price is currently -4.97% below its 50-day simple moving average

    RSI

    38.55
    JANX 14-day relative strength index is 38.55

    Volume

    0.72
    JANX 30-day relative volume is 0.72

    ATR

    $1.39
    JANX average true range is $1.39

    10-day Historical Volatility

    28.95%
    JANX 10-day historical volatility is 28.95%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $10.59M
    JANX annual revenue is $10.59 million

    Revenue Analysts estimate

    $1.17M
    JANX annual revenue is currently +807.54% higher than the consensus analysts' forecast

    Revenue 1-year change

    +30.99%
    JANX annual revenue is up +30.99% year-on-year

    Revenue Sector rank

    28.03%
    JANX annual revenue is higher than 28.03% of companies in Healthcare sector

    EPS

    EPS

    -$1.28
    JANX annual earnings per share is -$1.28

    EPS Analysts estimate

    -$2.05
    JANX annual earnings per share is currently -37.44% lower than the consensus analysts' forecast

    EPS 1-year change

    +3.03%
    JANX annual earnings per share is up +3.03% year-on-year

    EPS Sector rank

    49.58%
    JANX annual earnings per share is higher than 49.58% of companies in Healthcare sector

    Profit

    Gross profit

    -
    JANX annual gross profit value is unknown

    Gross margin

    -
    JANX annual gross profit margin value is unknown

    Operating profit

    -$98.85M
    JANX annual operating income is -$98.85 million

    Operating margin

    -933.58%
    JANX annual operating profit margin is -933.58%

    Net income

    -$68.99M
    JANX annual net profit is -$68.99 million

    Net margin

    -651.62%
    JANX annual net profit margin is -651.62%

    Expenses

    Total expenses

    $109.44M
    JANX annual total expenses is $109.44 million

    Operating expenses

    $109.44M
    JANX annual total operating expenses is $109.44 million

    Cost of goods sold

    -
    JANX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $41.05M
    JANX annual SGA is $41.05 million

    Depreciation and amortization

    $2.06M
    JANX annual depreciation & amortization is $2.06 million

    Interest expense

    -
    JANX annual interest expense value is unknown

    Income tax

    -
    JANX annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$98.85M
    JANX annual earnings before interest & taxes is -$98.85 million

    EBITDA

    -$96.79M
    JANX annual EBITDA is -$96.79 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.06B
    JANX annual total assets is $1.06 billion

    Non current assets

    $27.85M
    JANX annual long term assets is $27.85 million

    Current assets

    $1.03B
    JANX annual total current assets is $1.03 billion

    Cash and cash equivalents

    $430.61M
    JANX annual cash & cash equivalents is $430.61 million

    Accounts receivable

    -
    JANX annual accounts receivable value is unknown

    Inventory

    -
    JANX annual inventory value is unknown

    Liabilities

    Total liabilities

    $38.73M
    JANX annual total liabilities is $38.73 million

    Long term liabilities

    $21.28M
    JANX annual total long term liabilities is $21.28 million

    Current liabilities

    $17.46M
    JANX annual total current liabilities is $17.46 million

    Accounts payable

    $4.03M
    JANX annual accounts payable is $4.03 million

    Debt

    Total debt

    $23.02M
    JANX annual total debt is $23.02 million

    Total debt 1-year change

    -6.18%
    JANX annual total debt is down -6.18% year-on-year

    Long term debt

    $21.28M
    JANX annual long term debt is $21.28 million

    Short term debt

    $1.75M
    JANX annual short term debt is $1.75 million

    Equity & Capital

    Shareholders equity

    $1.02B
    JANX annual stockholders equity is $1.02 billion

    Book value

    $1.02B
    JANX annual book value is $1.02 billion

    Retained earnings

    -$237.76M
    JANX annual retained earnings is -$237.76 million

    Working capital

    $1.02B
    JANX annual working capital is $1.02 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$43.81M
    JANX annual cash flow from operations is -$43.81 million

    Cash from operations 1-year change

    +13.37%
    JANX annual cash flow from operations is up +13.37% year-on-year

    Cash from investing

    -$258.02M
    JANX annual cash flow from investing activities is -$258.02 million

    Cash from investing 1-year change

    -526.36%
    JANX annual cash flow from investing activities is down -526.36% year-on-year

    Cash from financing

    $713.24M
    JANX annual cash flow from financing activities is $713.24 million

    Cash from financing 1-year change

    +1097.75%
    JANX annual cash flow from financing activities is up +1097.75% year-on-year

    CAPEX

    CAPEX

    $359.00K
    JANX annual capital expenditures is $359.00 thousand

    CAPEX 1-year change

    -80.59%
    JANX annual capital expenditures is down -80.59% year-on-year

    Free Cash Flow

    Free cash flow

    -$44.17M
    JANX annual free cash flow is -$44.17 million

    Free cash flow 1-year change

    +15.74%
    JANX annual free cash flow is up +15.74% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    JANX annual gross profit margin value is unknown

    Operating margin

    -933.58%
    JANX annual operating profit margin is -933.58%

    Net margin

    -651.62%
    JANX annual net profit margin is -651.62%

    ROA & ROE

    ROA

    -9.57%
    JANX annual return on assets is -9.57%

    ROE

    -10.09%
    JANX annual return on equity is -10.09%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    JANX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    JANX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.38
    JANX price to book ratio is 1.38

    PB ratio Sector rank

    45.56%
    JANX price to book ratio is higher than 45.56% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    JANX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    JANX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $1.34B
    JANX enterprise value is $1.34 billion

    Enterprise value Sector rank

    76.9%
    JANX enterprise value is higher than 76.9% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -12.04
    JANX EV/EBITDA is -12.04

    EV/EBITDA Sector rank

    11.76%
    JANX EV/EBITDA is higher than 11.76% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    59.21
    JANX annual current ratio is 59.21

    Quick ratio

    -
    JANX annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    JANX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    JANX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    JANX piotroski f-score value is unknown

    Altman Z-Score

    22.13
    JANX altman z-score is 22.13

    Analyst ratings

    Recent major analysts updates

    Jul 11, 25 Raymond James
    Outperform
    Mar 3, 25 HC Wainwright & Co.
    Buy
    Feb 28, 25 Scotiabank
    Sector Perform
    Dec 11, 24 Cantor Fitzgerald
    Overweight
    Dec 4, 24 Scotiabank
    Sector Perform
    Dec 3, 24 Stifel
    Buy
    Dec 3, 24 Leerink Partners
    Outperform
    Dec 3, 24 HC Wainwright & Co.
    Buy
    Nov 22, 24 Leerink Partners
    Outperform
    Nov 7, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with JANX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Janux Therapeutics, Inc.?
    • Does Janux Therapeutics, Inc. pay dividends?
    • What sector is Janux Therapeutics, Inc. in?
    • What industry is Janux Therapeutics, Inc. in?
    • What country is Janux Therapeutics, Inc. based in?
    • When did Janux Therapeutics, Inc. go public?
    • Is Janux Therapeutics, Inc. in the S&P 500?
    • Is Janux Therapeutics, Inc. in the NASDAQ 100?
    • Is Janux Therapeutics, Inc. in the Dow Jones?
    • When was Janux Therapeutics, Inc.'s last earnings report?
    • When does Janux Therapeutics, Inc. report earnings?

    What is the ticker symbol for Janux Therapeutics, Inc.?

    The ticker symbol for Janux Therapeutics, Inc. is NASDAQ:JANX

    Does Janux Therapeutics, Inc. pay dividends?

    No, Janux Therapeutics, Inc. does not pay dividends

    What sector is Janux Therapeutics, Inc. in?

    Janux Therapeutics, Inc. is in the Healthcare sector

    What industry is Janux Therapeutics, Inc. in?

    Janux Therapeutics, Inc. is in the Biotechnology industry

    What country is Janux Therapeutics, Inc. based in?

    Janux Therapeutics, Inc. is headquartered in United States

    When did Janux Therapeutics, Inc. go public?

    Janux Therapeutics, Inc.'s initial public offering (IPO) was on June 11, 2021

    Is Janux Therapeutics, Inc. in the S&P 500?

    No, Janux Therapeutics, Inc. is not included in the S&P 500 index

    Is Janux Therapeutics, Inc. in the NASDAQ 100?

    No, Janux Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Janux Therapeutics, Inc. in the Dow Jones?

    No, Janux Therapeutics, Inc. is not included in the Dow Jones index

    When was Janux Therapeutics, Inc.'s last earnings report?

    Janux Therapeutics, Inc.'s most recent earnings report was on May 8, 2025

    When does Janux Therapeutics, Inc. report earnings?

    The next expected earnings date for Janux Therapeutics, Inc. is August 7, 2025
    On this page